We thank the readers for their keen interest in and comments on our study published in Neonatology [1] . In this study, nearly an equal proportion of infants enrolled in the trial had respiratory distress syndrome (RDS) as the admission diagnosis for respiratory distress. However, among the infants where the cause of respiratory distress was other than RDS, transient tachypnea of newborn or delayed clearance was present in 72 out of 133 (54%) in the high-flow nasal cannula (HFNC) group and 60 out of 139 (43%) in the nasal continuous positive airway pressure (nCPAP) group, respectively. One newborn in the nCPAP group was diagnosed with pneumonia. Among the infants with a cause of respiratory distress other than RDS, the failure rate was significantly higher in the HFNC group ( An updated meta-analysis including all recent trials is needed to improve the evidence base on the use of HFNC as primary respiratory support in preterm infants with respiratory distress. A close look at all the current trials (Table 1) comparing HFNC with nCPAP highlights some of these important findings [2] [3] [4] [5] .
The criteria for the failure rate are similar across all of the trials. The rescue mode in the HFNC group (either nCPAP or intubation with mechanical ventilation) was different in the separate trials, leading to the differences in the reporting of the trial results.
Infants with significant respiratory distress were not enrolled in most trials and InSurE as a therapy among enrolled infants was not a common adjunct in all. This may explain the different failure rates in the nCPAP groups across the trials.
Assuming all treatment failures in both groups were intubated in our study, the need for intubation or mechanical ventilation would have been significantly higher in the HFNC group (35/133 [26.3%] vs. 11/139 [7.9%], risk difference in treatment failure 18.4% with 95% CI 9.7-27.1%). Considering the results from our study and also from all the other recent trials, we strongly believe that HFNC is inferior to nCPAP in preterm infants with moderate or mild respiratory distress.
